Nucleate GVA | PATH: Intellectual Property Strategy for Life Science Founders

Speaker: Dr. Chris Vindurampulle (Principal, Patent and Trade Marks Attorney at Griffith Hack)

​Are you a life science researcher thinking about turning your discovery into a biotech startup? Learn how to think strategically about intellectual property, protect inventions before disclosure, and avoid common IP pitfalls on the path from lab discovery to commercialization.

​Turning academic research into a biotech company requires more than strong science. It also means understanding what kinds of intellectual assets you are creating, when to protect them, who owns them, and whether your future company will have the freedom to operate. In this session, Dr. Chris Vindurampulle, featured by the Nucleate Global Virtual Activator team, will walk through the key IP considerations researchers should understand when translating research into a startup.